Skip to main content

MoonLake Immunotherapeutics

MLTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001821586

In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in MoonLake Immunotherapeutics as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
125
+9 vs. Q3 2023
Shares held
59.3M
+3.07M (+5.5%) vs. Q3 2023
Total value
$3.53B
+$322.1M (+10.0%) vs. Q3 2023
New holders
37
51 more added
Sold out
28
33 more reduced

2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 125 institutions
Q1 2021: 42 institutionsQ2 2021: 46 institutionsQ3 2021: 43 institutionsQ4 2021: 45 institutionsQ1 2022: 27 institutionsQ2 2022: 23 institutionsQ3 2022: 24 institutionsQ4 2022: 33 institutionsQ1 2023: 43 institutionsQ2 2023: 83 institutionsQ3 2023: 118 institutionsQ4 2023: 125 institutionsQ1 2024: 114 institutionsQ2 2024: 111 institutionsQ3 2024: 109 institutionsQ4 2024: 116 institutionsQ1 2025: 136 institutionsQ2 2025: 130 institutionsQ3 2025: 134 institutionsQ4 2025: 130 institutionsQ1 2026: 147 institutionsQ2 2026: 172 institutions
Value heldQ4 2023: $3.53B
Q1 2021: $108.9MQ2 2021: $115.8MQ3 2021: $111.1MQ4 2021: $112.8MQ1 2022: $123.4MQ2 2022: $190.1MQ3 2022: $291.4MQ4 2022: $396.4MQ1 2023: $843.2MQ2 2023: $2.86BQ3 2023: $3.21BQ4 2023: $3.53BQ1 2024: $2.99BQ2 2024: $2.67BQ3 2024: $3.14BQ4 2024: $3.43BQ1 2025: $2.34BQ2 2025: $2.77BQ3 2025: $269.7MQ4 2025: $742.9MQ1 2026: $1.17BQ2 2026: $1.43B
Institutions holding MLTX and their total value by quarter
QuarterHoldersValue
Q2 2026172$1.43B
Q1 2026147$1.17B
Q4 2025130$742.9M
Q3 2025134$269.7M
Q2 2025130$2.77B
Q1 2025136$2.34B
Q4 2024116$3.43B
Q3 2024109$3.14B
Q2 2024111$2.67B
Q1 2024114$2.99B
Q4 2023125$3.53B
Q3 2023118$3.21B
Q2 202383$2.86B
Q1 202343$843.2M
Q4 202233$396.4M
Q3 202224$291.4M
Q2 202223$190.1M
Q1 202227$123.4M
Q4 202145$112.8M
Q3 202143$111.1M
Q2 202146$115.8M
Q1 202142$108.9M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q3 2023.

Institutions holding MLTX in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Integral Health Asset Management, LLC220,000$13.3M1.92%−280,000−56.0%Reduced
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.228,992$13.8M3.15%+228,992New
Invesco Ltd.238,231$14.4M0.00%−12,002−4.8%Reduced
Wellington Management Group LLP257,192$15.5M0.00%−166,195−39.3%Reduced
MPM Oncology Impact Management LP294,576$17.8M4.16%+386+0.1%Added
5AM Venture Management, LLC302,630$18.3M4.85%−10,580−3.4%Reduced
BlackRock Inc.381,726$23.1M0.00%−367,152−49.0%Reduced
TimesSquare Capital Management, LLC488,805$29.5M0.43%+77,590+18.9%Added
Balyasny Asset Management LLC598,510$36.1M0.10%+364,260+155.5%Added
Westfield Capital Management Co LP612,050$37.0M0.22%+220,771+56.4%Added
Pictet Asset Management Holding SA616,563$37.2M0.04%+74,662+13.8%Added
Fred Alger Management, LLC810,586$49.0M0.26%−22,365−2.7%Reduced
Alliancebernstein L.P.909,151$54.9M0.02%+437,832+92.9%Added
Polar Capital Holdings Plc937,115$56.6M0.39%−1,897−0.2%Reduced
Holocene Advisors, LP961,330$58.1M0.23%+855,508+808.4%Added
Darwin Global Management, Ltd.1,039,289$62.8M12.32%+1,039,289New
Federated Hermes, Inc.1,060,526$64.0M0.16%−23,724−2.2%Reduced
T. Rowe Price Investment Management, Inc.1,220,602$73.7M0.05%+5,879+0.5%Added
Adage Capital Partners GP, L.L.C.1,525,717$92.1M0.19%−426,986−21.9%Reduced
Citadel Advisors LLC2,008,660$121.3M0.12%−25,736−1.3%Reduced
Price T Rowe Associates Inc2,314,012$139.7M0.02%+196,144+9.3%Added
Avoro Capital Advisors LLC2,580,000$155.8M2.15%+580,001+29.0%Added
FMR LLC3,847,678$232.4M0.02%+450,425+13.3%Added
Cormorant Asset Management, LP8,494,151$513.0M24.56%+352,051+4.3%Added
BVF Inc21,751,284$1.31B32.87%00.0%Unchanged
Avidity Partners Management LP0$00.00%−777,172−100.0%Sold out
RTW Investments, LP0$00.00%−500,000−100.0%Sold out
Franklin Resources Inc0$00.00%−212,773−100.0%Sold out
OrbiMed Advisors LLC0$00.00%−117,000−100.0%Sold out
Altium Capital Management LP0$00.00%−88,000−100.0%Sold out
Ameriprise Financial Inc0$00.00%−86,862−100.0%Sold out
Atika Capital Management LLC0$00.00%−85,000−100.0%Sold out
Walleye Capital LLC0$00.00%−67,926−100.0%Sold out
Velan Capital Investment Management LP0$00.00%−55,300−100.0%Sold out
Monashee Investment Management LLC0$00.00%−50,000−100.0%Sold out
SEI Investments Co0$00.00%−31,790−100.0%Sold out
Marshall Wace, LLP0$00.00%−30,451−100.0%Sold out
Moody Aldrich Partners LLC0$00.00%−25,655−100.0%Sold out
EAM Investors, LLC0$00.00%−20,917−100.0%Sold out
SVB Financial Group0$00.00%−16,173−100.0%Sold out
Gilder Gagnon Howe & Co LLC0$00.00%−14,959−100.0%Sold out
Renaissance Technologies LLC0$00.00%−13,396−100.0%Sold out
ArrowMark Colorado Holdings LLC0$00.00%−10,000−100.0%Sold out
Maven Securities LTD0$00.00%−10,000−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−6,918−100.0%Sold out
DekaBank Deutsche Girozentrale0$00.00%−6,200−100.0%Sold out
Walleye Trading LLC0$00.00%−5,425−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−4,352−100.0%Sold out
Group One Trading, L.P.0$00.00%−4,234−100.0%Sold out
Belvedere Trading LLC0$00.00%−3,931−100.0%Sold out
US Bancorp0$00.00%−3,547−100.0%Sold out
Dorsey Wright & Associates0$00.00%−1,074−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−200−100.0%Sold out
CHI Advisors LLC––––Not filed
First Republic Investment Management, Inc.––––Not filed